Pub. Date : 2016 Apr
PMID : 26656632
6 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model. | gemcitabine | epidermal growth factor receptor | Homo sapiens |
| 2 | UNLABELLED: In this study, we have formulated redox-responsive epidermal growth factor receptor (EGFR)-targeted type B gelatin nanoparticles as a targeted vector for systemic delivery of gemcitabine therapy in pancreatic cancer. | gemcitabine | epidermal growth factor receptor | Homo sapiens |
| 3 | UNLABELLED: In this study, we have formulated redox-responsive epidermal growth factor receptor (EGFR)-targeted type B gelatin nanoparticles as a targeted vector for systemic delivery of gemcitabine therapy in pancreatic cancer. | gemcitabine | epidermal growth factor receptor | Homo sapiens |
| 4 | Our in vitro studies in Panc-1 human pancreatic ductal adenocarcinoma cells confirm that gemcitabine encapsulated in EGFR-targeted gelatin nanoparticles, released through disulfide bond cleavage, had a significantly improved cytotoxic profile. | gemcitabine | epidermal growth factor receptor | Homo sapiens |
| 5 | In this study, the authors presented their formulation of redox-responsive epidermal growth factor receptor (EGFR)-targeted type B gelatin nanoparticles as a carrier for gemcitabine. | gemcitabine | epidermal growth factor receptor | Homo sapiens |
| 6 | In this study, the authors presented their formulation of redox-responsive epidermal growth factor receptor (EGFR)-targeted type B gelatin nanoparticles as a carrier for gemcitabine. | gemcitabine | epidermal growth factor receptor | Homo sapiens |